相关实验视频

Updated: May 23, 2025

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography

Published on: July 10, 2018

普罗波对过敏性鼻炎小鼠II型炎症的抑制作用

Xi Chen¹, Wenxing Liu², Xiaohua Guo³

¹Department of Anesthesiology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China. 877579351@qq.com.

Iranian journal of allergy, asthma, and immunology

|March 7, 2025

概括

麻醉剂普罗波通过调节小鼠的II组先天性淋巴细胞 (ILC2s) 和T助手2 (TH2) 反应来减少过敏性鼻炎的炎症.

科学领域:

免疫学免疫学免疫学
过敏研究研究过敏
药理学药理学是指药理学的学科.

背景情况:

过敏性鼻炎 (AR) 涉及T助手2 (TH2) 炎症,其中2组先天性淋巴细胞 (ILC2) 起着重要作用.
普罗波是一种广泛使用的麻醉剂,已知具有抗炎性质.

研究的目的:

在过敏性鼻炎的小鼠模型中研究普罗波福对ILC2s和TH2炎症的影响.
阐明普罗波对AR的先天性和适应性免疫作用的潜在机制.

主要方法:

建立一个对卵素 (OVA) 敏感和受到挑战的小鼠模型.
使用Giemsa染色,ELISA和流动细胞计量,分析鼻洗液和组织的炎症细胞,细胞因子 (IL-5,IL-13) 和ILC2s.
在实验室内培养ILC2s和CD4+T细胞以评估TH2细胞分化,有或没有propofol和抗MHC II抗体.

主要成果:

普罗波治疗显著降低了II型细胞因子,炎症细胞数量 (乙酸性细胞,中性细胞,巨细胞) 和鼻腔中的ILC2频率.
GATA3,RORα,IL-5和IL-13的鼻腔表达被普罗波显著抑制.
普罗波在共同培养中降低了TH2细胞分化,这种效应部分由MHCII类相互作用中介.

结论:

普罗波在小鼠模型中显示出对过敏性鼻炎的抑制作用.
普罗波调节了与AR有关的先天性 (ILC2s) 和适应性 (TH2细胞) 免疫反应.
这些发现表明propofol作为过敏性鼻炎的治疗剂的潜力.

关键词:

过敏性鼻炎是一种过敏性鼻炎.第二组是先天性淋巴细胞.普罗波福尔 (Propofol) 是一种

更多相关视频

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Published on: September 22, 2023

Intra-tracheal Administration of Haemophilus influenzae in Mouse Models to Study Airway Inflammation

Intra-tracheal Administration of Haemophilus influenzae in Mouse Models to Study Airway Inflammation

Published on: March 2, 2016

相关概念视频

Drugs Used in Lower Respiratory Disorders: Overview

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...

Asthma-II: Pathophysiology and Classification

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include: